|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 409 12th Street, SW |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400578740-12
|
||||||||
|
6. House ID# 412490000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Kira Peterson |
Date | 4/20/2023 4:06:33 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Physician workforce/training (general); Risk Evaluation and Mitigation Strategy (REMS) for Mifepristone (general); Abortion (general); Breast Cancer (general); Coverage of follow up screenings and test for cervical, breast, and lung cancer; Health IT (general); Patient-Physician Relationship (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Teaching Health Center Graduate Medical Education (general); Health professional student loan repayment (General); Womens Preventive Services (general); Administrative Burden (general); Health Insurance Portability and Accountability Act (general); Maternal Mental Health (general); Contraception (general); Inclusion of Pregnant and Lactating Populations in Research (general); Health care for incarcerated women (general); H.R.___/S.___, Preventing Maternal Deaths Act; Care for individuals with disabilities (general); H.Res. 28, Resolution Condemning the Supreme Court's decision to overturn Roe v. Wade and Planned Parenthood v. Casey and committing to advancing reproductive justice and judicial reform; Provider incentive programs related to pregnancy (general); H.R.___/S.___, PREEMIE Act; H.R. 459, Secure Access for Essential Reproductive (SAFER) Health Act; H.R. 1117/S.___, Advancing Safe Medications for Moms and Babies Act; H.R.___/S.___, Protecting Reproductive Freedom Act; Reauthorization of the Pandemics and All Hazards Preparedness Act; Abortion training (general); Remote device monitoring during pregnancy and postpartum; Residential Treatment for Pregnant and Postpartum Women program (SAMHSA); H.R. 12/S. 701, Women's Health Protection Act; H.R. 561/S. 1031, EACH Act of 2023; H.R. 26/S. 204, Born-Alive Abortion Survivors Protection Act; Implementation of P.L. 115-320, Improving Access to Maternity Care Act; H.R. 1475, Hospital Adoption Education Act; Implementation of P.L. 117-328, Consolidated Appropriations Act, including the Pregnant Workers Fairness Act and Into the Light for Maternal Mental Health and Substance Use Disorders Act; H.R.___, Black Maternal Health Momnibus Act; H.R. ___/S.___, CONNECT for Health Act; Implementation of the No Surprises Act contained in P.L. 116-260; H.R.___/S.___, SHINE for Autumn Act; S.Res. 90, A resolution recognizing the significance of endometriosis as an unmet chronic disease for women and designating March 2023 as "Endometriosis Awareness Month.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS), Substance Abuse & Mental Health Services Administration (SAMHSA), Office of Management & Budget (OMB), White House Office, Executive Office of the President (EOP), Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Drew |
Hatter |
|
|
|
Rebecca |
Lauer |
|
|
|
Erin |
Lambie |
|
|
|
Taylor |
Platt |
|
|
|
Rachel |
Tetlow |
|
|
|
Lisa |
Satterfield |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Postpartum Medicaid coverage (general); Physician payment under Medicare (general); Telehealth (general); Public Health Emergency Medicaid Continuous Coverage Unwinding; Protecting Medicaid (general); Durable Medical Equipment (general); Maternal Mortality and Morbidity (general); Implementation of P.L. 117-328, Consolidated Appropriations Act, including permanent postpartum Medicaid extension; S. 712, Connected MOM Act; Prior Authorization; H.R.1526 /S.765, Reducing Hereditary Cancer Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lisa |
Satterfield |
|
|
|
Drew |
Hatter |
|
|
|
Rebecca |
Lauer |
|
|
|
Erin |
Lambie |
|
|
|
Taylor |
Platt |
|
|
|
Rachel |
Tetlow |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Obstetric care at military treatment facilities; Department of Defense Abortion Policies (general).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Drew |
Hatter |
|
|
|
Rebecca |
Lauer |
|
|
|
Rachel |
Tetlow |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Abortion (general); Contraception (general); Maternal health care at the Department of Veterans Affairs (general).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Drew |
Hatter |
|
|
|
Rebecca |
Lauer |
|
|
|
Rachel |
Tetlow |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Migrant family detention policies; Relief for DACA recipients in health professions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), Justice - Dept of (DOJ), Health & Human Services - Dept of (HHS), U.S. Citizenship & Immigration Services (USCIS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Drew |
Hatter |
|
|
|
Rebecca |
Lauer |
|
|
|
Rachel |
Tetlow |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Office of Research on Women's Health (NIH); Advanced Research Projects Agency for Health (ARPA-H); programs supporting contraceptive access in primary care settings (general); Centers for Disease Control and Prevention (CDC); Safe Motherhood and Infant Health Program; Public health surveillance at CDC; Gun Violence Prevention Research; Surveillance for Emerging Threats to Mothers and Babies (SET-NET); National Center for Health Statistics (NCHS); Data Modernization Initiative (DMI); Center for Forecasting and Outbreak Analytics (CFA); Health Resources and Services Administration (HRSA); National Health Service Corps; Teaching Health Center Graduate Medical Education; Alliance for Innovation on Maternal Health; National Maternal Mental Health Hotline; Screening and Treatment for Maternal Mental Health and Substance Use Disorders program; Title V Maternal and Child Health (MCH) Services Block Grant; Title VII Health Workforce Programs (general); Title VIII Health Workforce Programs (general); Graduate Medical Education funding through the Indian Health Service; Agency for Healthcare Research & Quality (AHRQ); United Nations Population Fund (UNFPA); international family planning and reproductive health programs (general); Global Gag Rule; International family planning programs (general); International reproductive rights (general); Helms Amendment; HIV Working Capital Fund; Kemp-Kasten Amendment; Title X family planning program (general); Office of Population Affairs; Teen Pregnancy Prevention Program, Division of STD Prevention at CDC; sexually transmitted disease (STD) prevention (general), Special Supplemental Nutrition Program for Women, Infants, and Children (WIC); Substance use and addiction workforce programs; Maternal Mortality and Morbidity; Inclusion of Pregnant and Lactating Populations in Research; Substance Use Disorder Treatment; Newborn Screening (general); Department of Defense Congressionally Directed Medical Research Programs (CDMRP); FY 24 Departments of Labor, Health and Human Services (HHS), and Education and Related Agencies appropriations bill.
17. House(s) of Congress and Federal agencies Check if None
Centers For Disease Control & Prevention (CDC), Office of Management & Budget (OMB), Natl Institutes of Health (NIH), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Food & Drug Administration (FDA), Justice - Dept of (DOJ), Centers For Medicare and Medicaid Services (CMS), Agency for Healthcare Research & Quality (AHRQ), Indian Health Service, Defense - Dept of (DOD), Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Rebecca |
Lauer |
|
|
|
Drew |
Hatter |
|
|
|
Lisa |
Satterfield |
|
|
|
Erin |
Lambie |
|
|
|
Taylor |
Platt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
Global HER Act (H.R.1838).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, State - Dept of (DOS), U.S. Agency for International Development (USAID)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Rebecca |
Lauer |
|
|
|
Drew |
Hatter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1202/S.704, Resident Education Deferred Interest (REDI) Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Rebecca |
Lauer |
|
|
|
Drew |
Hatter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |